• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促甲状腺激素受体跨膜结构域的结构与激活

Structure and activation of the TSH receptor transmembrane domain.

作者信息

Núñez Miguel Ricardo, Sanders Jane, Furmaniak Jadwiga, Smith Bernard Rees

机构信息

FIRS Laboratories, RSR Ltd, Parc Ty Glas, Llanishen, Cardiff, CF14 5DU, UK.

出版信息

Auto Immun Highlights. 2017 Dec;8(1):2. doi: 10.1007/s13317-016-0090-1. Epub 2016 Dec 5.

DOI:10.1007/s13317-016-0090-1
PMID:27921237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5136658/
Abstract

PURPOSE

The thyroid-stimulating hormone receptor (TSHR) is the target autoantigen for TSHR-stimulating autoantibodies in Graves' disease. The TSHR is composed of: a leucine-rich repeat domain (LRD), a hinge region or cleavage domain (CD) and a transmembrane domain (TMD). The binding arrangements between the TSHR LRD and the thyroid-stimulating autoantibody M22 or TSH have become available from the crystal structure of the TSHR LRD-M22 complex and a comparative model of the TSHR LRD in complex with TSH, respectively. However, the mechanism by which the TMD of the TSHR and the other glycoprotein hormone receptors (GPHRs) becomes activated is unknown.

METHODS

We have generated comparative models of the structures of the inactive (TMD_In) and active (TMD_Ac) conformations of the TSHR, follicle-stimulating hormone receptor (FSHR) and luteinizing hormone receptor (LHR) TMDs. The structures of TMD_Ac and TMD_In were obtained using class A GPCR crystal structures for which fully active and inactive conformations were available.

RESULTS

Most conserved motifs observed in GPCR TMDs are also observed in the amino acid sequences of GPHR TMDs. Furthermore, most GPCR TMD conserved helix distortions are observed in our models of the structures of GPHR TMDs. Analysis of these structures has allowed us to propose a mechanism for activation of GPHR TMDs.

CONCLUSIONS

Insight into the mechanism of activation of the TSHR by both TSH and TSHR autoantibodies is likely to be useful in the development of new treatments for Graves' disease.

摘要

目的

促甲状腺激素受体(TSHR)是格雷夫斯病中促甲状腺激素受体刺激性自身抗体的靶自身抗原。TSHR由富含亮氨酸的重复结构域(LRD)、铰链区或裂解结构域(CD)和跨膜结构域(TMD)组成。TSHR LRD与促甲状腺刺激性自身抗体M22或促甲状腺激素(TSH)之间的结合方式已分别从TSHR LRD-M22复合物的晶体结构和TSHR LRD与TSH复合物的比较模型中获得。然而,TSHR的TMD以及其他糖蛋白激素受体(GPHRs)被激活的机制尚不清楚。

方法

我们生成了TSHR、促卵泡激素受体(FSHR)和促黄体生成素受体(LHR)TMD的非活性(TMD_In)和活性(TMD_Ac)构象的结构比较模型。TMD_Ac和TMD_In的结构是使用具有完全活性和非活性构象的A类GPCR晶体结构获得的。

结果

在GPCR TMD中观察到的大多数保守基序在GPHR TMD的氨基酸序列中也有观察到。此外,在我们的GPHR TMD结构模型中观察到了大多数GPCR TMD保守螺旋扭曲。对这些结构的分析使我们能够提出一种GPHR TMD激活机制。

结论

深入了解TSH和TSHR自身抗体激活TSHR的机制可能有助于开发格雷夫斯病的新治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf0/5136658/0824a2d60ec2/13317_2016_90_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf0/5136658/d6a678e3ad02/13317_2016_90_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf0/5136658/dfe3d38119c1/13317_2016_90_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf0/5136658/0824a2d60ec2/13317_2016_90_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf0/5136658/d6a678e3ad02/13317_2016_90_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf0/5136658/dfe3d38119c1/13317_2016_90_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf0/5136658/0824a2d60ec2/13317_2016_90_Fig3_HTML.jpg

相似文献

1
Structure and activation of the TSH receptor transmembrane domain.促甲状腺激素受体跨膜结构域的结构与激活
Auto Immun Highlights. 2017 Dec;8(1):2. doi: 10.1007/s13317-016-0090-1. Epub 2016 Dec 5.
2
Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.基于突变和对受体晶体结构此区域模糊性的重新评估,深入了解甲状腺刺激自身抗体与促甲状腺素受体 N 端的相互作用。
Thyroid. 2011 Sep;21(9):1013-20. doi: 10.1089/thy.2011.0147. Epub 2011 Aug 11.
3
FSH and TSH binding to their respective receptors: similarities, differences and implication for glycoprotein hormone specificity.促卵泡激素(FSH)和促甲状腺激素(TSH)与其各自受体的结合:相似性、差异及对糖蛋白激素特异性的影响
J Mol Endocrinol. 2008 Sep;41(3):145-64. doi: 10.1677/JME-08-0040. Epub 2008 Jul 7.
4
Similarities and differences in interactions of thyroid stimulating and blocking autoantibodies with the TSH receptor.甲状腺刺激和阻断自身抗体与 TSH 受体相互作用的异同。
J Mol Endocrinol. 2012 Aug 30;49(2):137-51. doi: 10.1530/JME-12-0040. Print 2012 Oct.
5
Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions.促甲状腺素自身抗体M22模拟促甲状腺激素与促甲状腺激素受体富含亮氨酸结构域的结合:蛋白质-蛋白质相互作用的比较结构研究
J Mol Endocrinol. 2009 May;42(5):381-95. doi: 10.1677/JME-08-0152. Epub 2009 Feb 16.
6
The full-length TSH receptor is stabilized by TSH ligand.全长 TSH 受体受 TSH 配体稳定。
J Mol Graph Model. 2024 Jun;129:108725. doi: 10.1016/j.jmgm.2024.108725. Epub 2024 Feb 11.
7
Glycosylation pattern analysis of glycoprotein hormones and their receptors.糖蛋白激素及其受体的糖基化模式分析。
J Mol Endocrinol. 2017 Jan;58(1):25-41. doi: 10.1530/JME-16-0169. Epub 2016 Nov 14.
8
Effects of a thyroid-stimulating human monoclonal autoantibody (M22) on functional activity of LH and FSH receptors.一种促甲状腺素人单克隆自身抗体(M22)对促黄体生成素(LH)和促卵泡生成素(FSH)受体功能活性的影响。
Thyroid. 2006 Nov;16(11):1085-9. doi: 10.1089/thy.2006.16.1085.
9
Hormone- and antibody-mediated activation of the thyrotropin receptor.促甲状腺激素受体的激素和抗体介导的激活。
Nature. 2022 Sep;609(7928):854-859. doi: 10.1038/s41586-022-05173-3. Epub 2022 Aug 8.
10
Analysis of the thyrotropin receptor-thyrotropin interaction by comparative modeling.通过比较建模分析促甲状腺激素受体与促甲状腺激素的相互作用。
Thyroid. 2004 Dec;14(12):991-1011. doi: 10.1089/thy.2004.14.991.

引用本文的文献

1
Structural basis of signaling regulation of the human melanocortin-2 receptor by MRAP1.MRAP1 调控人黑素皮质素 2 受体信号转导的结构基础。
Cell Res. 2023 Jan;33(1):46-54. doi: 10.1038/s41422-022-00751-6. Epub 2023 Jan 2.
2
Structure of full-length TSH receptor in complex with antibody K1-70™.全长 TSH 受体与抗体 K1-70™复合物的结构。
J Mol Endocrinol. 2022 Dec 7;70(1). doi: 10.1530/JME-22-0120. Print 2023 Jan 1.
3
Evaluation of analytic and clinical performance of two immunoassays for detecting thyroid-stimulating receptor antibody in the diagnosis of Graves' disease.

本文引用的文献

1
Rearrangement of the Extracellular Domain/Extracellular Loop 1 Interface Is Critical for Thyrotropin Receptor Activation.细胞外结构域/细胞外环1界面的重排对促甲状腺激素受体激活至关重要。
J Biol Chem. 2016 Jul 1;291(27):14095-14108. doi: 10.1074/jbc.M115.709659. Epub 2016 Apr 26.
2
Current updates on computer aided protein modeling and designing.计算机辅助蛋白质建模与设计的最新进展。
Int J Biol Macromol. 2016 Apr;85:48-62. doi: 10.1016/j.ijbiomac.2015.12.072. Epub 2015 Dec 28.
3
Molecular Insights into the Transmembrane Domain of the Thyrotropin Receptor.
评价两种免疫分析法在 Graves 病诊断中检测甲状腺刺激受体抗体的分析和临床性能。
J Clin Lab Anal. 2021 Dec;35(12):e23950. doi: 10.1002/jcla.23950. Epub 2021 Nov 9.
4
2021 update on thyroid-associated ophthalmopathy.2021 年甲状腺相关眼病更新。
J Endocrinol Invest. 2022 Feb;45(2):235-259. doi: 10.1007/s40618-021-01663-9. Epub 2021 Aug 20.
5
Cryo-EM: A new dawn in thyroid biology.冷冻电镜:甲状腺生物学的新纪元。
Mol Cell Endocrinol. 2021 Jul 1;531:111309. doi: 10.1016/j.mce.2021.111309. Epub 2021 May 5.
6
Implications of an Improved Model of the TSH Receptor Transmembrane Domain (TSHR-TMD-TRIO).TSHR-TMD-TRIO 跨膜结构域改良模型的意义。
Endocrinology. 2021 Jul 1;162(7). doi: 10.1210/endocr/bqab051.
7
The Role of Hormones and Trophic Factors as Components of Preservation Solutions in Protection of Renal Function before Transplantation: A Review of the Literature.激素和营养因子作为保存液成分在移植前保护肾功能中的作用:文献复习。
Molecules. 2020 May 7;25(9):2185. doi: 10.3390/molecules25092185.
8
Receptor autoimmunity: diagnostic and therapeutic implications.受体自身免疫:诊断及治疗意义
Auto Immun Highlights. 2020 Jan 7;11(1):1. doi: 10.1186/s13317-019-0125-5.
9
Structural Biology Helps Interpret Variants of Uncertain Significance in Genes Causing Endocrine and Metabolic Disorders.结构生物学有助于解读导致内分泌和代谢紊乱的基因中意义未明的变异体。
J Endocr Soc. 2018 Jun 13;2(8):842-854. doi: 10.1210/js.2018-00077. eCollection 2018 Aug 1.
10
Structural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work.促甲状腺激素受体的结构功能特征:发挥作用的A类G蛋白偶联受体
Front Endocrinol (Lausanne). 2017 Apr 24;8:86. doi: 10.3389/fendo.2017.00086. eCollection 2017.
促甲状腺激素受体跨膜结构域的分子见解
PLoS One. 2015 Nov 6;10(11):e0142250. doi: 10.1371/journal.pone.0142250. eCollection 2015.
4
Constitutive Activity among Orphan Class-A G Protein Coupled Receptors.孤儿A类G蛋白偶联受体中的组成性活性。
PLoS One. 2015 Sep 18;10(9):e0138463. doi: 10.1371/journal.pone.0138463. eCollection 2015.
5
Novel Inactivating Mutation of the FSH Receptor in Two Siblings of Indian Origin With Premature Ovarian Failure.印度裔两名患有卵巢早衰的同胞姐妹中促卵泡激素受体的新型失活突变
J Clin Endocrinol Metab. 2015 Jun;100(6):2154-7. doi: 10.1210/jc.2015-1401. Epub 2015 Apr 15.
6
Functional characterization of two naturally occurring mutations (Val514Ala and Ala575Val) in follicle-stimulating hormone receptor.促卵泡激素受体中两个自然发生的突变(Val514Ala和Ala575Val)的功能特性
J Clin Endocrinol Metab. 2015 Apr;100(4):E638-45. doi: 10.1210/jc.2014-3662. Epub 2015 Jan 12.
7
Transmembrane domains of attraction on the TSH receptor.促甲状腺激素受体上的跨膜吸引域。
Endocrinology. 2015 Feb;156(2):488-98. doi: 10.1210/en.2014-1509. Epub 2014 Nov 19.
8
Monte Carlo loop refinement and virtual screening of the thyroid-stimulating hormone receptor transmembrane domain.甲状腺刺激激素受体跨膜结构域的蒙特卡罗循环优化与虚拟筛选
J Biomol Struct Dyn. 2015;33(5):1140-52. doi: 10.1080/07391102.2014.932310. Epub 2014 Jul 11.
9
A newly discovered TSHR variant (L665F) associated with nonautoimmune hyperthyroidism in an Austrian family induces constitutive TSHR activation by steric repulsion between TM1 and TM7.在一个奥地利家族中发现的一种新的 TSHR 变体(L665F)与非自身免疫性甲亢有关,它通过 TM1 和 TM7 之间的空间排斥作用诱导 TSHR 的组成型激活。
J Clin Endocrinol Metab. 2014 Oct;99(10):E2051-9. doi: 10.1210/jc.2014-1436. Epub 2014 Jun 20.
10
Alpha-bulges in G protein-coupled receptors.G 蛋白偶联受体中的α-隆起。
Int J Mol Sci. 2014 May 6;15(5):7841-64. doi: 10.3390/ijms15057841.